Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.
Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.
Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.
“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.
No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.
The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.
Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.
Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.
Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.
Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.
Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.
Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.
Credit: X
Olympic hurdler and bobsledder Lolo Jones has revealed that she suffered a debilitating spinal injury during bobsled training, lost bladder control, and was allegedly denied timely medical care, raising serious concerns about athlete health and safety within the U.S. Olympic system.
Jones shared her experience after reports of the the events surrounding a training accident ahead of the 2025 IBSF World Championships in Lake Placid surfaced.
According to the reports, she sustained a severe lower back injury while testing a new bobsled but continued competing because her condition was never diagnosed at the time.
During the training session, Lolo Jones experienced symptoms like intense lower back pain, numbness, leg weakness, foot drop, and loss of bladder control; all of which can be warning signs of cauda equina syndrome, a rare but serious condition caused by compression of nerves at the base of the spinal cord.
It is a medical emergency as delayed treatment can result in permanent paralysis or loss of bladder and bowel function.
Despite these symptoms, Jones alleges she did not receive urgent medical evaluation. Reports claim that when she visited the U.S. Olympic Training Center's sports medicine clinic seeking treatment, her scheduled massage appointment had been canceled, and she was not provided immediate imaging such as an MRI or X-ray.
Convinced she was dealing with a painful but manageable injury, Jones continued to compete in the World Championships, completing multiple high-speed bobsled runs. She later said that had the sled crashed during competition, she could have been left permanently paralysed.
After returning home, Jones reportedly paid for her own MRI, which revealed the extent of the damage. The scan showed a herniated disc, additional disc bulges, and tears involving the L3, L4 and L5 levels of her spine, with leaking spinal fluid. She subsequently underwent spinal surgery at her own expense.
Jones also claims that after surgery she was denied access to training and rehabilitation facilities at the Olympic Training Center, forcing her to fund her own recovery, rehabilitation, travel and training. According to reports, the financial burden exceeded $100,000.
The athlete has since called for greater accountability and reforms in athlete medical care, especially who compete in the Olympics.
In a public statement, Jones wrote that she had "never even been given an X-ray or an MRI" despite her symptoms and said she wanted to help ensure other athletes do not face similar situations.
Experts consider loss of bladder control, leg weakness, numbness around the saddle area, and severe lower back pain to be serious symptoms that need immediate emergency assessment.
Prompt diagnosis, usually with an MRI, and urgent surgery when cauda equina syndrome is confirmed can significantly improve the chances of preserving nerve function and preventing the risk of paralysis.
Jones is one of the few athletes to have competed at both the Summer and Winter Olympics, representing the United States in hurdles and bobsled.
Her latest allegations have sparked renewed discussion about whether elite athletes receive timely access to appropriate medical attention when serious injuries occur.
Credit: iStock
Amid raging wildfires, France is preparing for its fourth major heatwave of the year as extreme temperatures and bone-dry conditions in the southwest intensify the challenges faced by crews battling a massive wildfire in the Bordeaux region.
Temperatures in Bordeaux were expected to reach 33°C (91°F) during the day, around 7°C above the average high recorded between 1961 and 1990, according to the Reuters Climate Monitor.
"The situation we are dealing with today is the most severe we have ever recorded, the toughest since the Second World War," said President Emmanuel Macron.
Firefighters managed to contain the blaze overnight, but the situation remained difficult, with reports suggesting the wildfire threat could continue until November.
France is experiencing an unprecedented wildfire season, with the area affected by fires already surpassing the previous record set in 2022. Around 4000 more people were evacuated from tourist sites along the Atlantic coast, following the evacuation of more than 250,000 people earlier.
Also read: Europe Swelters Under Heatwave And Wildfires; 360,000+ Evacuated: What Are The Health Risks?
Meanwhile, the UK is also preparing for its fourth heatwave of the summer, with temperatures expected to climb to 34°C in parts of the country later this week.
Several amber and yellow heat alerts have been issued as the UK Health Security Agency (UKHSA) warned that rising temperatures could increase health risks, particularly for vulnerable groups.
Temperatures are forecast to reach 29°C in southeast England on Tuesday before rising further to 34°C on Wednesday.
Read More: Could Wildfire Smoke Trigger Your Migraine? Latest Study Finds A Strong Link
The heatwave follows an exceptionally hot and dry June, which has left some of the UK’s driest regions without rainfall for weeks. Forecasters have warned that parts of southern and southeast England could face “exceptionally severe” wildfire conditions this week due to extreme heat and prolonged dry weather.
Parts of Wales have already been placed under drought status, while large areas of England remain under “prolonged dry weather” status — the final stage before a drought declaration.
According to the Medicines and Healthcare products Regulatory Agency (MHRA), high temperatures can affect medicines and reduce how well they work.
Rising temperatures can affect how some medicines work in the body, posing potential risks for people with long-term health conditions. Experts say simple precautions can help prevent heat-related complications.
Medicines that do not require refrigeration, including tablets, inhalers, hormone replacement therapy (HRT) patches, and epinephrine, should generally be stored in a cool, dry place at room temperature, ideally between 15°C and 25°C. This is because high temperatures can reduce the potency and effectiveness of the active ingredients in medicines.
Alison Cave, Chief Safety Officer at the MHRA, said that when there’s a heatwave, medicines left in the heat – in cars, bags, or on sunny windowsills – might not work properly when you need them.
“Some medicines can also make you more likely to burn in the sun, feel dizzy, or get dehydrated, especially if you’re taking diuretics or have a condition like asthma, heart disease, or diabetes.”
To stay safe during hot weather, the MHRA advised people to:
Credit: iStock
Stroke is among the leading causes of disability worldwide, and many survivors are left struggling with speech difficulties. After a stroke, some people lose the ability to speak fluently despite being able to understand language and, remarkably, sing familiar songs they have known for years.
This connection between music and speech recovery forms the basis of Melodic Intonation Therapy (MIT), an evidence-based approach that uses melody, rhythm, and repetition to help patients regain communication abilities.
Music therapy works by activating brain networks that remain functional even when areas responsible for speech or movement are damaged.
Speaking to HealthandMe, Dr. Sudhir Kumar, Neurologist at Apollo Hospitals, Hyderabad, explained that rhythm helps retrain the brain’s motor circuits. In stroke patients with movement difficulties, rhythmic auditory stimulation — where movements are synchronised with a steady beat — can help improve walking patterns.
“Music therapy taps into brain networks that survive a stroke even when speech or movement pathways are damaged. Rhythm helps retrain the brain's motor circuits. Patients with gait difficulties often walk more fluidly when moving to a steady beat, a technique we call rhythmic auditory stimulation,” Dr. Sudhir said.
Dr. K. K. Jindal, Director – Neurology, CK Birla Hospital, Delhi, said that after a stroke, the brain can reorganize itself and form new neural connections through a process called neuroplasticity.
“Music, and in particular rhythm and melody, can cause several areas of the brain to be activated at once,” Dr. Jindal told HealthandMe.
He added that techniques like Melodic Intonation Therapy can support communication in patients with speech difficulties, while rhythmic auditory stimulation has helped improve gait, physical coordination, and balance during stroke recovery.
Dr Kumar said for patients with aphasia — a condition that affects speech and language after stroke — singing can engage the right hemisphere of the brain, allowing some patients to produce words through melody even when they are unable to speak normally.
Experts said that beyond neurological benefits, music may also help reduce anxiety and depression, which are common after stroke and can slow recovery.
“Music therapy is not a replacement for conventional rehabilitation, but a scientifically grounded complement to it,” Dr. Sudhir said.
Dr. Jindal also stated that while music therapy cannot substitute treatments such as physiotherapy or speech therapy, it can serve as an effective supportive measure during recovery.
Building on this approach, researchers from IIT Delhi, in collaboration with AIIMS New Delhi and the Institute of Human Behaviour and Allied Sciences (IHBAS), have developed the first Hindi version of Melodic Intonation Therapy.
While MIT has traditionally been used in English, researchers adapted the therapy for Hindi by modifying words, melodies, and rhythmic patterns to match the language’s natural stress patterns and cadence.
The team developed exercises based on how Hindi speakers communicate in everyday life, making the therapy more culturally and linguistically relevant for Indian patients.
The pilot study, published in the international journal Aphasiology, was conducted between December 2023 and March 2024.
The study included six Hindi-speaking stroke survivors who underwent 40 therapy sessions each. Each session lasted 45 to 60 minutes and was conducted by trained speech therapists.
All participants completed the program and showed clinically meaningful improvements. Researchers reported improvements in sentence formation, speech fluency, and quality-of-life measures.
“Patients were able to string together longer sentences, spoke more freely, and reported gains in their quality of life. There were no adverse effects,” said Prof. Rahul Garg, one of the researchers leading the study.
Researchers cautioned that the findings are preliminary due to the small number of participants involved and said that further research is needed to confirm the results.
© 2024 Bennett, Coleman & Company Limited